Form 4: Natures Sunshine CFO Vests Performance-Based Shares

Natures Sunshine Products Inc.'s EVP & CFO, Leslie Shane Jones, acquired 4,004 common shares through the vesting of performance-based restricted stock units and had 1,756 shares withheld for tax purposes.

Summary

• Leslie Shane Jones, EVP & Chief Financial Officer of Natures Sunshine Products Inc. (NATR), reported transactions on November 4, 2025.
• Jones acquired 4,004 common shares due to the vesting of performance-based restricted stock units.
• This vesting was triggered by the achievement of an adjusted EBITDA milestone of $46.2 million over a rolling 12-month period.
• The original grant date for these performance-based restricted stock units was April 20, 2023.
• Half of the target shares vested upon milestone achievement, with the remaining half set to vest one year later.
• Concurrently, 1,756 common shares were disposed of (withheld) to cover tax liabilities associated with the vesting, at a price of $13.75 per share.
• Following these transactions, Jones beneficially owns 108,592 common shares directly.

Sentiment

Score: 7

Explanation: The filing indicates the achievement of a significant financial milestone (adjusted EBITDA of $46.2M), leading to the vesting of performance-based restricted stock units for a key executive. This suggests strong company performance and good alignment of executive incentives. The share withholding for taxes is a routine event.

Positives

• Achievement of an adjusted EBITDA milestone of $46.2 million, indicating strong financial performance by the company.
• Vesting of performance-based restricted stock units for the EVP & CFO, aligning management incentives with company performance.

Negatives

• 1,756 shares were withheld to cover tax liabilities, representing a reduction in the total shares beneficially owned by the officer.

Future Outlook

Half of the performance-based restricted stock units that vested will be followed by the vesting of the remaining half one year after the achievement of the adjusted EBITDA milestone.

Management Comments

• The vesting of shares resulted from the achievement of an adjusted EBITDA milestone of $46.2 million over a rolling 12-month period, pursuant to an April 20, 2023, performance-based restricted stock unit grant.

Industry Context

This filing reflects a standard executive compensation event tied to performance, common in the health and wellness industry for aligning management incentives with company financial goals. The achievement of an EBITDA milestone suggests positive operational performance for Natures Sunshine Products within its sector.

Comparison to Industry Standards

• The use of performance-based restricted stock units tied to specific financial metrics like adjusted EBITDA is a common practice in executive compensation across various industries, including health and wellness.
• Companies like Herbalife Nutrition (HLF) and USANA Health Sciences (USNA) also utilize similar long-term incentive plans to motivate executives and align their interests with shareholder value.
• The $46.2 million adjusted EBITDA milestone indicates a specific, measurable target, which is a robust approach to performance-based vesting, comparable to best practices seen in other publicly traded companies.

Stakeholder Impact

• Shareholders: Positive signal regarding company performance due to the achievement of an EBITDA milestone, which triggered executive RSU vesting. Also, increased alignment of executive interests with shareholder value.
• Employees: No direct impact mentioned, but overall company performance can indirectly affect employee morale and future opportunities.

Next Steps

• The remaining half of the performance-based restricted stock units will vest one year following the achievement of the adjusted EBITDA milestone.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event where performance-based restricted stock units vested due to the achievement of a pre-defined EBITDA milestone. While the milestone achievement is a positive indicator of company performance, the transaction itself is expected and does not introduce new fundamental information that would warrant a change in investment recommendation. It reinforces management's alignment with company success but doesn't suggest a significant shift in the company's outlook or valuation.

Keywords

Natures Sunshine Products, NATR, Leslie Shane Jones, CFO, SEC Form 4, Insider Trading, Stock Vesting, Restricted Stock Units, EBITDA Milestone, Executive Compensation